S. David Kimball

Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.

Alan G. E. Wilson, D. Augeri, S. D. Kimball, 2009, Journal of medicinal chemistry.

N-(cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent.

Punit Marathe, John S Tokarski, J. Tokarski, 2004, Journal of medicinal chemistry.

Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents.

S. Moreland, S. D. Kimball, M. Malley, 1992, Journal of medicinal chemistry.

Novel L-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.

Alan G. E. Wilson, N. C. Goodwin, F. Mseeh, 2009, Journal of medicinal chemistry.

Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.

Alan G. E. Wilson, D. Augeri, J. Tarver, 2009, Journal of medicinal chemistry.

Discovery of aminothiazole inhibitors of cyclin-dependent kinase 2: synthesis, X-ray crystallographic analysis, and biological activities.

Punit Marathe, John S Tokarski, Toomas Mitt, 2002, Journal of medicinal chemistry.